| pubmed-article:1263317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0600139 | lld:lifeskim |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0441789 | lld:lifeskim |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
| pubmed-article:1263317 | lifeskim:mentions | umls-concept:C0356799 | lld:lifeskim |
| pubmed-article:1263317 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1263317 | pubmed:dateCreated | 1976-7-6 | lld:pubmed |
| pubmed-article:1263317 | pubmed:abstractText | We treated 50 patients with stage D carcinoma of the prostate with 15 mg. per kg. per day oral estramustine phosphate for 3 to 24 months. We are able to evaluate 44 patients. Objective remissions were induced in 8 of the 44 patients (19 per cent) and subjective remission occurred in all objective responders and in 7 additional patients for a subjective response of 15 of 44 (36 per cent). No hematologic or renal toxicity was encountered. Transient nausea occurred early in half of the patients and was dose limiting in 3 patients. One case of hepatic toxicity was seen. Oral estramustine phosphate is well tolerated and long-term therapy is feasible. | lld:pubmed |
| pubmed-article:1263317 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1263317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1263317 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1263317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1263317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1263317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1263317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1263317 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:1263317 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:1263317 | pubmed:author | pubmed-author:MurphyG PGP | lld:pubmed |
| pubmed-article:1263317 | pubmed:author | pubmed-author:ShuklaS KSK | lld:pubmed |
| pubmed-article:1263317 | pubmed:author | pubmed-author:MittelmanAA | lld:pubmed |
| pubmed-article:1263317 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1263317 | pubmed:volume | 115 | lld:pubmed |
| pubmed-article:1263317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1263317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1263317 | pubmed:pagination | 409-12 | lld:pubmed |
| pubmed-article:1263317 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:meshHeading | pubmed-meshheading:1263317-... | lld:pubmed |
| pubmed-article:1263317 | pubmed:year | 1976 | lld:pubmed |
| pubmed-article:1263317 | pubmed:articleTitle | Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate. | lld:pubmed |
| pubmed-article:1263317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1263317 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1263317 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1263317 | lld:pubmed |
